Concepedia

R. Cameron

RC

Statistics

Publications

10

Citations

710

H-Index

10

Active since

1990

Affiliations

Novartis (United Kingdom)(Current)

Novartis (Switzerland)

Respiratory Research Institute

LungenClinic Grosshansdorf

Drexel University

R. Cameron is an author at Novartis (United Kingdom) specializing in pharmacotherapy, respiratory pharmacotherapy, and pulmonology.

Publications per year

1990–2014

10

Publications

10

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

Marc Decramer, Kenneth R. Chapman, Ronald Dahl et al. · The Lancet Respiratory Medicine · 2013 · 275 citations

, , +9

INSTEAD: a randomised switch trial of indacaterol <i>versus</i> salmeterol/fluticasone in moderate COPD

Andrea Rossi, Thys van der Molen, Ricardo del Olmo et al. · European Respiratory Journal · 2014 · 122 citations · Full text

, , +16

Indacaterol, a novel inhaled β<sub>2</sub>-agonist, provides sustained 24-h bronchodilation in asthma

KM Beeh, Eric Derom, Frank Kanniess et al. · European Respiratory Journal · 2007 · 72 citations · Full text

, , +16

Indacaterol provides sustained 24 h bronchodilation on once‐daily dosing in asthma: a 7‐day dose‐ranging study

Craig LaForce, Michael J. Alexander, Regina Deckelmann et al. · Allergy · 2007 · 52 citations · Full text

, , +17

Safety and tolerability of indacaterol in asthma: A randomized, placebo-controlled 28-day study

A N Tsoĭ, Kai Richter, Norbert Krug et al. · Respiratory Medicine · 2007 · 51 citations

, , +7

1–5 of 10